why choose us

First received: February 22, 2023

Clinical Trial: A Pharmacist-run PrEP Program for Women

Study Status: Completed

Recruit Status: RECRUITING

Condition: HIV Prevention

Study Type: OBSERVATIONAL


Official Title: A Pharmacist-run, Community-based PrEP Program for High-risk women-the OPTIMIZE Study

Brief Summary: The primary objective of this study is to evaluate uptake and retention of long acting cabotegravir (LA-CAB) also known as Apretude versus daily oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) also known as Truvada for PrEP among high-risk women in metro-Orlando through week 48 (to also include reasons for lack of retention in PrEP care)

Read more